Thus, mitigating insulin resistance through the upregulated AMPK/PI3K/Akt/eNOS pathway seems to be a crucial therapeutic opportunity to combat FFAs-induced ED and subsequent CVD events. Here, NOS3 is linked to Insulin resistance.